Squarepoint’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $890K | Sell |
390,294
-561,885
| -59% | -$1.78M | ﹤0.01% | 2874 |
|
|
2025
Q4 | $3.81M | Buy |
952,179
+754,585
| +382% | +$4.19M | ﹤0.01% | 1631 |
|
|
2025
Q3 | $1.67M | Buy |
+197,594
| New | +$1.92M | ﹤0.01% | 2242 |
|
|
2025
Q2 | – | Sell |
-35,052
| Closed | -$332K | – | 4641 |
|
|
2025
Q1 | $332K | Sell |
35,052
-4,468
| -11% | -$45.1K | ﹤0.01% | 3663 |
|
|
2024
Q4 | $445K | Buy |
+39,520
| New | +$695K | ﹤0.01% | 3824 |
|
|
2024
Q3 | – | Sell |
-22,980
| Closed | -$592K | – | 4256 |
|
|
2024
Q2 | $439K | Buy |
+22,980
| New | +$587K | ﹤0.01% | 3176 |
|
|
2024
Q1 | – | Sell |
-21,033
| Closed | -$695K | – | 4181 |
|
|
2023
Q4 | $695K | Buy |
+21,033
| New | +$595K | ﹤0.01% | 2775 |
|
|
2022
Q4 | – | Sell |
-13,249
| Closed | -$476K | – | 3289 |
|
|
2022
Q3 | $476K | Buy |
+13,249
| New | +$467K | ﹤0.01% | 2226 |
|
|
2022
Q2 | – | Sell |
-15,507
| Closed | -$501K | – | 3014 |
|
|
2022
Q1 | $501K | Sell |
15,507
-58,817
| -79% | -$1.54M | ﹤0.01% | 2012 |
|
|
2021
Q4 | $2.06M | Buy |
+74,324
| New | +$2.13M | 0.01% | 1240 |
|
|
2021
Q3 | – | Sell |
-49,656
| Closed | -$1.05M | – | 3043 |
|
|
2021
Q2 | $1.05M | Buy |
49,656
+22,890
| +86% | +$458K | ﹤0.01% | 1593 |
|
|
2021
Q1 | $541K | Buy |
+26,766
| New | +$509K | ﹤0.01% | 1956 |
|
|
2020
Q4 | – | Sell |
-50,903
| Closed | -$632K | – | 3005 |
|
|
2020
Q3 | $632K | Buy |
+50,903
| New | +$599K | 0.01% | 1250 |
|
|
2020
Q1 | – | Sell |
-61,586
| Closed | -$557K | – | 2044 |
|
|
2019
Q4 | $557K | Sell |
61,586
-156,504
| -72% | -$1.27M | ﹤0.01% | 1711 |
|
|
2019
Q3 | $1.57M | Buy |
+218,090
| New | +$1.57M | 0.01% | 958 |
|
|
2019
Q1 | – | Sell |
-19,691
| Closed | -$393K | – | 2225 |
|
|
2018
Q4 | $393K | Sell |
19,691
-4,409
| -18% | -$102K | ﹤0.01% | 1382 |
|
|
2018
Q3 | $684K | Sell |
24,100
-20,878
| -46% | -$498K | 0.01% | 1165 |
|
|
2018
Q2 | $947K | Buy |
+44,978
| New | +$851K | 0.01% | 916 |
|
|
2018
Q1 | – | Sell |
-69,996
| Closed | -$861K | – | 1809 |
|
|
2017
Q4 | $861K | Buy |
+69,996
| New | +$987K | 0.02% | 898 |
|
|
2017
Q1 | – | Sell |
-33,087
| Closed | -$490K | – | 1624 |
|
|
2016
Q4 | $490K | Buy |
+33,087
| New | +$652K | 0.02% | 837 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Squarepoint's EVH Position: Q1 2026 in Review
Squarepoint reduced its Evolent Health (EVH) stake by 59% in Q1 2026, selling an estimated $1.78M and leaving 390,294 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.
Squarepoint first reported a position in EVH in Q4 2016 and has held it in 20 quarters since. The position peaked at $3.81M in Q4 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Squarepoint held 390,294 shares of Evolent Health worth $890K as of Q1 2026.
- Squarepoint sold 561,885 Evolent Health shares in Q1 2026, an estimated $1.78M.
- Evolent Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2874 holding.
- Squarepoint first reported a position in Evolent Health in Q4 2016 and has held it in 20 quarters since.
- Squarepoint's Evolent Health position peaked at $3.81M in Q4 2025.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.